Clinical Trial Update: Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial [Phase 2]

View source ↗

Summary

A prospective Phase II study evaluating high-dose proton therapy for unresectable primary liver cancer (hepatocellular carcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Liver Neoplasm, Proton Therapy | Phase 2 | Status: UNKNOWN